A service provider’s experience providing telehealth services during the COVID-19 pandemic in a community-based opioid substitution clinic in Bangladesh

Springer Science and Business Media LLC - Tập 2 Số 1
Tanveer Khan Ibne Shafiq1, Kashem Shaikh1, Md. Ferdous Rahman1, Golam Sarwar1, Muhammad Manwar Morshed Hemel1, Tahir Khan1, Sujan Chowdhury1, Sharful Islam Khan1
1Programme for HIV and AIDS, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research (icddr,b), Dhaka, Bangladesh

Tóm tắt

Abstract Introduction The COVID-19 pandemic incurred numerous impediments on day-to-day emergency medical services including Opioid Substitution Therapy (OST) for People Who Inject Drugs (PWID). To prevent treatment cessation and lost to follow-up, we tried to implement an alternate mitigating intervention like telehealth. Methodology This research was conducted on a cohort of OST clients during the COVID-19 pandemic ( from 1st April 2020 to 31st March 2021) in Narayanganj, a port city adjacent to the capital Dhaka and one of the most COVID-affected districts, with a high PWID and HIV burden. The participants were male, female and transgender women who were all ex-PWID and were under OST services. A telehealth intervention model was designed and implemented in the OST clinic at Narayangonj. Quantitative data were collected during pre and post-intervention of telehealth services. Results A total of 297 OST clients of Narayangonj were provided with telehealth services from April 2020 to March 2021. The participants were predominantly male (98.7%), 37.7% were between 30–39 years of age. 39.4% of the telephone calls were related to COVID-19-related symptoms followed by 21.7% for opioid withdrawal, 12.5% for COVID-19 & vaccine-related information, 11.3% for chronic diseases like diabetes, hypertension and asthma, 9.3% for Skin and Soft Tissue Infection (SSTI), and 5.8% for methadone-related effects. There was an improvement in treatment retention (14.4% to 87%), loss to follow-up (20% to 8%), and overdose-related death (1.3% to 0%) from pre to post intervention of telehealth services. Conclusion From our experience, we found that the telehealth intervention is beneficial for the OST clients and thus ensures treatment continuity and retention, both of which serve as crucial success indicators of the OST programme. Using simply the mobile phone, this intervention can reduce structural and logistical needs like clinic spaces and fewer human resources, ensuring cost-effectiveness and value for money.

Từ khóa


Tài liệu tham khảo

COVID-19_impact_on_drug_use_in_Central_Asia_en.pdf, https://www.unodc.org/documents/centralasia/2020/August/3.08/COVID-19_impact_on_drug_use_in_Central_Asia_en.pdf. (Accessed 24 Dec 2022).

Brothers S, Viera A, Heimer R. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. J Subst Abuse Treat. 2021;131:108449.

Dunlop A, Lokuge B, Masters D, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020;17:26.

Alexander R, Ravi A, Barclay H, et al. Guidance for the Treatment and Management of COVID-19 Among People with Intellectual Disabilities. J Policy Pract Intellect Disabil. 2020;17:256–69.

Mallet J, Dubertret C, Le Strat Y. Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110070.

Ftouni R, AlJardali B, Hamdanieh M, et al. Challenges of Telemedicine during the COVID-19 pandemic: a systematic review. BMC Med Inform Decis Mak. 2022;22:207.

Samuels EA, Clark SA, Wunsch C, et al. Innovation During COVID-19: Improving Addiction Treatment Access. J Addict Med. 2020;14:e8–9.

Jones CM, Shoff C, Hodges K, et al. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA Psychiat. 2022;79:981–92.

Scott Kruse C, Karem P, Shifflett K, et al. Evaluating barriers to adopting telemedicine worldwide: A systematic review. J Telemed Telecare. 2018;24:4–12.

Aronowitz SV, Engel-Rebitzer E, Dolan A, et al. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives. Harm Reduct J. 2021;18:119.

Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence, https://www.who.int/publications/i/item/9789241547543. (Accessed 24 Dec 2022).

Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41:777–813.

The Global State of Harm Reduction 2022. Harm Reduction International, https://hri.global/flagship-research/the-global-state-of-harm-reduction/the-global-state-of-harm-reduction-2022/. (Accessed 23 Dec 2022).

Response to the COVID-19 Pandemic in Bangladesh, https://dashboard.unicefbangladesh.org/. (Accessed 23 Dec 2022).

WHO Global Observatory for eHealth. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth. World Health Organization, https://apps.who.int/iris/handle/10665/44497. (2010, Accessed 23 Dec 2022).

Behavioural and Serological Surveillance amongst Key Populations at Risk of HIV in Selected Areas of Bangladesh, 2016 REPORT AIDS/STD Programme (ASP) Directorate General of Health Services Ministry of Health and Family Welfare Govt. of the People’s Republic of Bangladesh, http://asp.portal.gov.bd/sites/default/files/files/asp.portal.gov.bd/page/4129b6d9_3565_48d5_8f89_ef37abb51732/2020-08-10-22-53-441586ce07ccd5e787b792da60812279.pdf. (2017, Accessed 1 Jan 2022).

2021–11–11–08–20–2e42979e261c0ae15d867387912c158b.pdf, http://www.dnc.gov.bd/sites/default/files/files/dnc.portal.gov.bd/annual_reports/fdcb3aab_5681_4973_9bc1_17b5909afbcb/2021-11-11-08-20-2e42979e261c0ae15d867387912c158b.pdf. (Accessed 25 Dec 2022).

Doraiswamy S, Abraham A, Mamtani R, et al. Use of Telehealth During the COVID-19 Pandemic: Scoping Review. J Med Internet Res. 2020;22:e24087.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 2 Số 1

Thông tin tác giả